| Trial ID: | L6764 |
| Source ID: | NCT00380445
|
| Associated Drug: |
Vildagliptin
|
| Title: |
Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Vildagliptin
|
| Outcome Measures: |
Primary: To explore whether vildagliptin augments insulin mediated inhibition of adipose tissue lipid mobilization following a mixed meal in patients with type 2 diabetes | Secondary: To measure the effects of vildagliptin on tissue carbohydrate metabolism (skeletal muscle)
|
| Sponsor/Collaborators: |
Sponsor: Novartis
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
21
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-01
|
| Completion Date: |
2007-04
|
| Results First Posted: |
|
| Last Update Posted: |
2017-02-23
|
| Locations: |
Novartis Pharmaceuticals, East Hanover, New Jersey, 07936, United States|Novartis Investigative Site, Investigative Centers, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00380445
|
